Recursion CFO has 25,018 shares withheld for taxes
RECURSION PHARMACEUTICALS, INC.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
RECURSION PHARMACEUTICALS, INC. (RXRX) reported that its Chief Financial Officer, Ben R. Taylor, had 25,018 shares of Class A Common Stock withheld on 2026-08-17 to satisfy tax withholding and remittance obligations in connection with the net settlement of restricted stock units. This tax-withholding disposition was recorded at $3.16 per share, and Taylor now directly holds 1,076,858 shares of Class A Common Stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Tax Withholding | Class A Common Stock F1 | 25,018 | $3.16 | $79K |
Footnotes (1)
- F1. Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units.
Key Figures
Key Terms
restricted stock units financial
net settlement financial
tax withholding and remittance obligations financial
Class A Common Stock financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did RXRX disclose for CFO Ben R. Taylor?
Was the RXRX Form 4 transaction by CFO Ben R. Taylor a market sale?
Was the RXRX insider transaction by CFO Ben R. Taylor under a Rule 10b5-1 plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.